News
-
Increased Incidence of Anaplasmosis in Ontario, 2025
To: Ottawa Physicians and Nurse Practitioners
Date: September 16, 2025
From: Dr. Emil Prikryl, Associate Medical Officer of Health
Subject: Increased Incidence of Anaplasmosis in Ontario, 2025Dear Colleagues,
A recent report of a death in an Ottawa resident caused by anaplasmosis serves as a reminder that we remain very much in the season for tick-borne diseases such as
Sep 16, 2025
-
Information on Ontario's RSV Prevention Programs
To: Ottawa Physicians, Nurse Practitioners, and Midwives
Date: September 15, 2025
From: Dr. Laura Bourns, Deputy Medical Officer of Health
Subject: Information on Ontario’s RSV prevention programsDear Colleagues,
The below communication provides information on Respiratory Syncytial Virus (RSV) prevention programs the 2025-2026 RSV season for:
Please note: The RSV product order forms will be available at
Sep 15, 2025
-
Discontinuation of Provincial COVID-19 Test Results Viewer
To: Ottawa Physicians
Date: September 2, 2025
From: Dr. Laura Bourns, Deputy Medical Officer of Health
Subject: Discontinuation of Provincial COVID-19 Test Results ViewerDear Colleagues,
Please see below a memo from Ontario’s Chief Medical Officer of Health regarding the discontinuation of the provincial COVID-19 Test Results Viewer.
Sep 02, 2025
-
Market Withdrawal of COVID-19 KP.2 vaccines
To: Ottawa Physicians
Date: August 29, 2025
From: Dr. Laura Bourns, Deputy Medical Officer of Health
Subject: Market Withdrawal of COVID-19 KP.Aug 29, 2025
First Ottawa human case of West Nile Virus in 2025To: Ottawa Physicians and Nurse Practitioners
Date: Aug 27, 2025
From: Dr. Robin Taylor, Associate Medical Officer of HealthDear Colleagues,
Ottawa Public Health (OPH) is writing to heighten your awareness of the possibility of illness from West Nile virus (WNV) infection in Ottawa, as the first human case of WNV has been reported in an Ottawa resident for the 2025 season.
Aug 28, 2025
Updated PHO AEFI Reporting FormTo: Ottawa Physicians and Nurse Practitioners
Date: August 20, 2025
From: Dr. Laura Bourns, Deputy Medical Officer of Health
Subject: Updated PHO AEFI Reporting FormDear Colleagues,
In Ontario, Public Health Ontario (PHO) leads the provincial surveillance of adverse events following immunization (AEFIs).
Rabies Vaccine and Immunoglobulin SupplyTo: Ottawa Physicians and Nurse Practitioners
Date: August 18, 2025
From: Dr. Michelle Foote, Associate Medical Officer of Health
Subject: Rabies Vaccine and Immunoglobulin SupplyDear Colleagues,
Ontario is experiencing a shortage of rabies vaccines and rabies immunoglobulins (RabIg).
Confirmed case of measles in OttawaTo: Ottawa Physicians and Nurse Practitioners
Date: August 14, 2025
From: Dr. Michelle Foote, Associate Medical Officer of Health
Subject: Confirmed case of measles in OttawaDear Colleagues,
A case of measles has been reported to Ottawa Public Health with potential exposures to the virus for others in the community.
West Nile virus confirmed in Ottawa area mosquitoes 2025To: Ottawa Physicians and Nurse Practitioners
Date: August 12, 2025
From: Dr. Monir Taha, Associate Medical Officer of Health
Subject: West Nile virus confirmed in Ottawa area mosquitoesDear Colleagues,
Ottawa Public Health (OPH) is writing to heighten your awareness of the possibility of illness from West Nile virus (WNV) infection in Ottawa.
Syphilis testing update and screening recommendationsTo: Ottawa Physicians and Nurse Practitioners
Date: July 29, 2025
From: Dr. Michelle Foote, Associate Medical Officer of Health
Subject: Syphilis testing update and screening recommendationsPublic Health Ontario Laboratory (PHOL) has updated its testing approach for syphilis lesion specimens.
Welcome to the new OttawaPublicHealth.ca
Ottawa Public Health has moved to a refreshed website. During this transition, some links, redirects, documents, pages or display features may be temporarily affected.
Your feedback will help us review and address issues during the stabilization period.
This website uses cookies to enhance usability and provide you with a more personal experience. By using this website, you agree to our use of cookies as explained in our Privacy Policy.